[HTML] sciencedirect.com

[HTML][HTML] Pralatrexate Is Active in Cutaneous T-Cell Lymphoma (CTCL): Results of a Multicenter, Dose-Finding Trial.

SM Horwitz, M Duvic, Y Kim, JM Zain, MJ Lechowicz… - Blood, 2009 - Elsevier
Abstract Abstract 919 Background: Pralatrexate enters cancer cells via the reduced folate
carrier-1 (RFC-1) and is efficiently polyglutamated by folylpolyglutamyl synthetase (FPGS) …
被引用次数：12 相关文章

[引用][C] Pralatrexate is active in cutaneous T-cell lymphoma (CTCL): results of a multicenter, dose-finding trial

H SM - Blood, 2009 - cir.nii.ac.jp

Pralatrexate Is Active in Cutaneous T-Cell Lymphoma (CTCL): Results of a Multicenter, Dose-Finding Trial.

SM Horwitz, M Duvic, Y Kim, JM Zain, MJ Lechowicz… - 2009 - ashpublications.org
Abstract Abstract 919 Background: Pralatrexate enters cancer cells via the reduced folate
carrier-1 (RFC-1) and is efficiently polyglutamated by folylpolyglutamyl synthetase (FPGS) …